News | Ventricular Assist Devices (VAD) | August 05, 2022

When Heart-assisting Implants Could Save a Life, Black, Female Patients Don’t Get Them as Often 

Providers’ differential decision-making must be addressed to equalize chance of survival for heart failure patients, researchers say 

Providers’ differential decision-making must be addressed to equalize chance of survival for heart failure patients, researchers say

Getty Images


August 5, 2022 — Black people and women with severe heart failure who might be good candidates for surgery to implant a heart-assisting device have a lower chance of actually getting that operation than white patients, or male patients, a new study finds. 

The differences for Black patients cropped up mainly in patients whose chances of benefiting from a left-ventricular assist device (LVAD) were less clear-cut, usually because they had less severe heart failure. That meant it was up to their health care team and the patient to decide if they wanted to have the operation or continue with non-surgical treatment. 

The patterns of LVAD use in women, meanwhile, suggests lower access no matter how severe their heart failure. 

Differences by race and gender persisted even after the researchers took into account a raft of factors, from patients’ incomes and distance from the hospital to what their neighborhood population mix was like. 

That raises the strong possibility that for these patients, the chance of getting an LVAD was influenced by conscious or unconscious race and gender bias on the part of health care providers, the researchers conclude. 

And that means hospitals and heart failure teams need to take steps to ensure more equal access to LVAD care for all patients who might benefit, the authors say. 

The study, published in JAMA Network Open by a team from the University of Michigan Frankel Cardiovascular Center and Institute for Healthcare Policy and Innovation, is based on data from more than 12,300 patients with traditional Medicare coverage. All had heart failure severe enough to send them to the hospital at least once in the eight-year study period. 

The study shows no racial differences in LVAD use among the sickest heart failure patients, those who are the most clear-cut candidates. 

Instead, the differences in LVAD use for Black patients clustered among those with a less clear-cut need for the device. That need, based on specific clinical characteristics, is measured with what’s called an LVAD propensity score. In the group whose scores were “on the bubble”, Black patients had much lower chances of getting an LVAD than white or male patients. 

The researchers also looked at what happened after patients received an LVAD. Overall, patients survived for at least a year at equal rates, no matter what their race or gender.  Black patients in the “on the bubble” group actually had a higher chance of surviving at least a year than white patients (84% vs. 77%), even though they had a slightly higher chance of needing another hospital stay. 

“These data show clear racial disparities in cases where there is ‘wiggle room’ for clinicians to decide which patients are most likely to benefit from an LVAD,” says lead author Thomas Cascino, M.D., M.S., a cardiologist and health equity researcher at Michigan Medicine, U-M’s academic medical center. “There is less aggressive use of this life-saving therapy among a subgroup of Black patients and all women with heart failure. While we also need to study the role of patient preference in LVAD decision-making for this group of patients, heart failure providers need to be cognizant of their potential for bias and how it might influence the recommendations we make to patients.” 

Cascino and colleagues recently looked at another aspect of heart failure device care – the use of short-term mechanical circulatory support in patients who are candidates for a heart transplant. This analysis also suggested that center-level variation in use plays a major role in this type of care, which could in turn create inequality in a patient’s likelihood of being chosen for a heart transplant when an organ becomes available.  The team published the paper in the Journal of Heart and Lung Transplantation. 

For more information: https://med.umich.edu/ 

 

Related content: 

Study of National Registry Uncovers Racial Disparities Around Anticoagulation for Atrial Fibrillation 

UofL Study Shows Improvement in Heart Transplant Access, Outcomes for Black Patients 

Racial Disparities Seen in Treatment for Patients with Acute Coronary Syndrome and History of Cocaine Use 

Related Content

News | Heart Failure

August 8, 2022 — A major risk factor for diabetes, insulin resistance occurs when the cells of the body do not respond ...

Home August 08, 2022
Home
News | Heart Failure

August 5, 2022 — For people with coronary heart disease, beta-blockers can improve survival and quality of life, while ...

Home August 05, 2022
Home
News | Heart Failure

July 27, 2022 — The world’s first HIV-positive to HIV-positive heart transplant has been successfully performed at ...

Home July 27, 2022
Home
News | Heart Failure

July 27, 2022 — Researchers from RCSI University of Medicine and Health Sciences have developed a new lab-based model of ...

Home July 27, 2022
Home
News | Heart Failure

July 20, 2022 — Sequana Medical NV, a pioneer in the treatment of drug-resistant fluid overload in liver disease and ...

Home July 20, 2022
Home
News | Heart Failure

July 15, 2022 — The American Heart Association, the leading voluntary organization devoted to longer, healthier lives ...

Home July 15, 2022
Home
News | Heart Failure

July 13, 2022 — Ancora Heart, Inc., a company developing a novel device-based therapy to address heart failure, today ...

Home July 13, 2022
Home
News | Heart Failure

July 12, 2022 — Pesticides and heavy metals in soil may have detrimental effects on the cardiovascular system, according ...

Home July 12, 2022
Home
News | Heart Failure

July 7, 2022 — Tenaya Therapeutics, Inc., a biotechnology company with a mission to discover, develop and deliver ...

Home July 07, 2022
Home
News | Heart Failure

June 29, 2022 — A spiral wave of electrical activity in the heart can cause catastrophic consequences. One spiral wave ...

Home June 29, 2022
Home
Subscribe Now